Rahul Sharma

Rahul Sharma

Active Director Director DIN 09051931
DIN 09051931 First appointment Feb 2021 Primary industry Real Estate
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Rahul Sharma

Data last updated:

Rahul Sharma is a Director at Nayralis Pharma Private Limited (since 2021). The company operates in Real Estate. Nayralis Pharma Private Limited reported revenue of ₹8.1 Lakh (FY 2022).

DIN 09051931
Primary Designation Director
Industry Real Estate
First Appointment 04 Feb 2021
Oldest Company Age 9 yrs
Largest company Nayralis Pharma Private Limited · ₹8.1 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nayralis Pharma Private Limited U70200MH2017PTC296214
Director04 Feb 20212017₹8.1 Lakh (FY 2022)Active

Board colleagues of Rahul Sharma

Directorship timeline

Open interactive timeline →
Nayralis Pharma Private Limited
Premium access

Shareholding and investment profile for Rahul Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Sharma

Rahul Sharma currently holds 1 directorship: Nayralis Pharma Private Limited (Director, since 04 Feb 2021, revenue ₹8.1 Lakh (FY 2022)).

Rahul Sharma was first appointed on 04 Feb 2021 as Director at Nayralis Pharma Private Limited.

The current boards of Rahul Sharma's companies include Prajakta Ajay Karambe (Nayralis Pharma Private Limited), Sailee Vijay Kolhatkar (Nayralis Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available